Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion type Assertion NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_head.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion description "[Adoptive cell transfer (ACT), either using rapidly expanded tumor infiltrating lymphocytes or T-cell receptor transduced peripheral blood lymphocytes, can be considered one of the most promising approaches in cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_provenance.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion evidence source_evidence_literature NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_provenance.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion SIO_000772 20349059 NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_provenance.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion wasDerivedFrom befree-20140225 NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_provenance.
- NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_assertion wasGeneratedBy ECO_0000203 NP154917.RA15giWlVH24wAC9wrbnL3oiYBQdLgQLOGA46bg_KV-cA130_provenance.